Showing 1 - 5 results of 5 for search 'Elena S. Ratner', query time: 0.03s Refine Results
  1. 1
    Opsoclonus-ataxia syndrome and mature ovarian teratoma in an adolescent

    Opsoclonus-ataxia syndrome and mature ovarian teratoma in an adolescent by Emily M. Webster, Joan Tymon-Rosario, Johanna D'Addario, Burak Zeybek, Elena S. Ratner

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Corrigendum to "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)" [Gynecol. Oncol. Rep. 31 (2020) 100532]

    Corrigendum to "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutation... by Alessandro D. Santin, Virginia Filiaci, Stefania Bellone, Roisin O'Cearbhaill, Elena S. Ratner, Cara A. Mathews, Guilherme Cantuaria, Camille C. Gunderson, Teresa Rutledge, Barbara M. Buttin, Heather A. Lankes, Michael J. Birrer

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer

    Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer by Benjamin B. Albright, Jonathan D. Black, Rachel Passarelli, Stefan Gysler, Margaret Whicker, Gary Altwerger, Gulden Menderes, Natalia Buza, Pei Hui, Alessandro D. Santin, Masoud Azodi, Dan-Arin Silasi, Elena S. Ratner, Babak Litkouhi, Peter E. Schwartz

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)

    Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncolo... by Alessandro D. Santin, Virginia Filiaci, Stefania Bellone, Elena S. Ratner, Cara A. Mathews, Guilherme Cantuaria, Camille C. Gunderson, Teresa Rutledge, Barbara M. Buttin, Heather A. Lankes, Michael Frumovitz, Samir N. Khleif, Warner K. Huh, Michael J. Birrer

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study

    Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study by Emily M. Webster, Ghanshyam S. Yadav, Stefan Gysler, Blair McNamara, Jonathan Black, Joan Tymon-Rosario, Burak Zeybek, Chanhee Han, Christopher K. Arkfeld, Vaagn Andikyan, Gulden Menderes, Gloria Huang, Masoud Azodi, Dan-Arin Silasi, Alessandro D. Santin, Peter E. Schwartz, Elena S. Ratner, Gary Altwerger

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: